Table 1.

Selected characteristics of 295 women with stage III ovarian cancer included in the Danish MALOVA study according to ovarian cancer–specific survival status

CharacteristicsAlive/censored (N = 50), n (%)Dead from ovarian cancer (N = 245), n (%)
Age at diagnosis (y)
    <402 (4.0)5 (2.0)
    40-4912 (24.0)42 (17.1)
    50-5919 (38.0)82 (33.5)
    60-6914 (28.0)63 (25.7)
    ≥703 (6.0)53 (21.6)
Histologic type
    Serous adenocarcinomas40 (80.0)185 (75.5)
    Mucinous adenocarcinoma1 (2.0)14 (5.7)
    Endometrioid adenocarcinoma2 (4.0)14 (5.7)
    Clear cell neoplasms2 (4.0)8 (3.3)
    Papillary adenocarcinoma NOS4 (8.0)20 (8.2)
    Undifferentiated carcinomas1 (2.0)4 (1.6)
Primary surgery radical
    Yes15 (30.0)16 (6.5)
    No34 (68.0)183 (74.7)
    No, only biopsies taken1 (2.0)45 (18.4)
    Unknown01 (0.4)
Platinum-based chemotherapy
    Yes49 (98.0)209 (85.3)
    No1 (2.0)36 (14.7)
BMI (kg/m2) at age 20-29 y
    <18.54 (8.0)28 (11.4)
    18.5-24.942 (84.0)182 (74.3)
    ≥25.03 (6.0)28 (11.4)
    Unknown1 (2.0)7 (2.9)
BMI (kg/m2) 5 y before diagnosis
    <18.52 (4.0)10 (4.1)
    18.5-24.939 (78.0)137 (55.9)
    ≥25.08 (16.0)95 (38.8)
    Unknown1 (2.0)3 (1.2)
Smoking status
    Current smoker13 (26.0)77 (31.4)
    Former smoker14 (28.0)64 (26.1)
    Never smoker23 (46.0)103 (42.0)
    Unknown01 (0.4)
Duration of smoking (y)
    ≤96 (22.2)11 (7.8)
    10-196 (22.2)13 (9.2)
    20-293 (11.1)31 (22.0)
    30-394 (14.8)36 (25.5)
    ≥407 (25.9)50 (35.5)
    Unknown1 (3.7)0
Maximum daily tobacco use (g/d)
    ≤96 (22.2)23 (16.3)
    10-145 (18.5)32 (22.7)
    15-192 (4.0)23 (16.3)
    20-2410 (37.0)43 (30.5)
    ≥25.03 (11.1)18 (12.8)
    Unknown1 (3.7)2 (1.4)
Time since stop of smoking (y)
    ≤43 (21.4)20 (31.3)
    5-142 (14.3)20 (31.3)
    ≥159 (64.3)24 (37.5)